Elevated pulmonary vascular resistance is associated with increased risk of death in IPF

A. Kapasi (Edmonton, Canada), K. Halloran (Edmonton, Canada), A. Hirji (Edmonton, Canada), D. Lien (Edmonton, Canada), J. Mooney (Palo Alto, United States of America), R. Raj (Palo Alto, United States of America), A. Sweatt (Palo Alto, United States of America), J. Weinkauf (Edmonton, Canada), R. Zamanian (Palo Alto, United States of America)

Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension
Session: Pulmonary hypertension with lung diseases and experimental pulmonary hypertension
Session type: Thematic Poster
Number: 1428
Disease area: Interstitial lung diseases, Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Kapasi (Edmonton, Canada), K. Halloran (Edmonton, Canada), A. Hirji (Edmonton, Canada), D. Lien (Edmonton, Canada), J. Mooney (Palo Alto, United States of America), R. Raj (Palo Alto, United States of America), A. Sweatt (Palo Alto, United States of America), J. Weinkauf (Edmonton, Canada), R. Zamanian (Palo Alto, United States of America). Elevated pulmonary vascular resistance is associated with increased risk of death in IPF. 1428

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Elevated pulmonary vascular resistance predicts mortality in COPD patients
Source: Eur Respir J, 58 (2) 2100944; 10.1183/13993003.00944-2021
Year: 2021



Pulmonary vascular resistance predicts mortality in patients with pulmonary hypertension associated with interstitial lung disease: results from the COMPERA registry
Source: Eur Respir J, 58 (2) 2101483; 10.1183/13993003.01483-2021
Year: 2021



Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPD
Source: Eur Respir J 2016; 47:1365-1373
Year: 2016



Elevated circulating adiponectin levels in chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary embolism
Year: 2010

Increased risk of peripheral arterial disease in individuals with COPD
Source: International Congress 2017 – Prevalence, prognosis and comorbidities of COPD and factors associated with lung function
Year: 2017

Elevated serum LOXL2 levels are associated with rapid disease progression in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Year: 2012

COPD is associated with an increased risk of peripheral artery disease and mortality
Source: ERJ Open Res, 4 (4) 00086-2018; 10.1183/23120541.00086-2018
Year: 2018



Borderline pulmonary hypertension is associated with exercise intolerance and increased risk for acute exacerbation in patients with interstitial lung disease
Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle
Year: 2018

Reduced pulmonary vascular response to hypoxia is associated with endothelial dysfunction in chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 173s
Year: 2001

Elevated levels of adenosine in the lungs lead to chronic lung injury and pulmonary hypertension
Source: Annual Congress 2011 - Experimental pulmonary hypertension
Year: 2011

Diaphragm dysfunction in combination with lung function decline is associated with higher mortality in idiopathic pulmonary fibrosis patients
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018

Elevated circulating MMP-9 is associated with increased exacerbation risk in COPD: results from SPIROMICS and COPDGene
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018



Increased TNFα production in whole blood is associated with disease severity in COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 497s
Year: 2002

Elevated cardiac troponin I levels in acute pulmonary embolism predict increased long-term mortality
Source: Eur Respir J 2005; 26: Suppl. 49, 271s
Year: 2005

VEGF reduces pulmonary hypertension and vascular remodeling in pulmonary fibrosis through reduced endothelial apoptosis
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009

Biomarkers in pulmonary hypertension associated to interstitial lung disease
Source: Annual Congress 2010 - Pulmonary circulation II
Year: 2010

Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease
Source: Eur Respir J 2012; 39: 125-132
Year: 2012



Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease
Source: Eur Respir J 2011; 39: 125-132
Year: 2012



Is pulmonary hypertension associated with a leakage or an activation of endothelial cells?
Source: Eur Respir J 2003; 22: Suppl. 45, 74s
Year: 2003

Pulmonary vascular disease(PC) and risk of mortality in patients with idiopathic pulmonary fibrosis(IPF)
Source: International Congress 2018 – Pulmonary embolism: long-term sequelae and advances in therapies
Year: 2018